Citations

Showing 10 of 108152 citations.

Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis
Becerra, Clara M. Castillejo , Crowson, Cynthia S. , Bhatti, M. Tariq , Chen, John J. , Castillejo Becerra, Clara M, Chen, John J , Castillejo Becerra, Clara M , Koster, Matthew J. , Warrington, Kenneth J.

Mayo Clinic

Neuro-Ophthalmology | August 20, 2021 | Volume: 46 | Issue: 2 | Pages: 75-79

10.1080/01658107.2021.1965627 | PMID 35273408 Get It

The obesity paradox and orthopedic surgery
Hennrikus, Matthew T., Hennrikus, William, Lehman, Erik , Skolka, Michael , Hennrikus, Eileen , Skolka, Michael P

Mayo Clinic

Medicine | August 20, 2021 | Volume: 100 | Issue: 33 | Pages: e26936

10.1097/md.0000000000026936 | PMID 34414951 Get It

Abstract The Obesity Paradox describes the counterintuitive finding that although obesity contributes to the development of chronic conditions such as chronic kidney disease and cardiovascular disease, obesity seems to improve mortality in patients with these diseases. This paradox has also been sited in the critical care literature in regard to acute kidney injury, obesity and mortality. This study's objective is to examine the impact of obesity and post-surgical acute kidney injury on hospital length of stay and 2-year mortality after orthopedic surgery. We reviewed the electronic medical records of all adult elective orthopedic surgery patients over 2 years in a large academic hospital. The 1783 patients who met inclusion criteria were divided into obese (body mass index, BMI ≥ 30, n = 1123) and non-obese groups (BMI <30, n = 660). Demographics, medications, comorbidities, and perioperative variables were included in multivariable logistic regression analyses with acute kidney injury, length of hospital stay, and two-year mortality as primary outcomes. Outcomes were analyzed for the entire group, the obese cohort and the non-obese cohort. Acute kidney injury developed in 5% of the post-surgical orthopedic patients. Obesity increased the likelihood of developing acute kidney injury post orthopedic surgery (odds ratio [OR] = 1.82; 95% Confidence interval [CI] 1.05–3.15, P = .034). Acute kidney injury increased length of stay by 1.3 days and increased the odds of two-year mortality (OR = 2.08; 95% CI 1.03–4.22, P = .041). However, obese patients had a decreased likelihood of two-year mortality (OR = 0.53; 95% CI 0.33–0.84, P = .009). In adult orthopedic surgery patients, obesity increased the risk of acute kidney injury. Patients who developed an acute kidney injury had longer hospital stays and higher two-year mortality. Paradoxically, obesity decreased two-year mortality.
Time for a New 3-D Image for Globus Pallidus Internus Deep Brain Stimulation Targeting and Programming
Wong, Joshua K. , Hilliard, Justin D. , Holanda, Vanessa M. , Gunduz, Aysegul , Foote, Kelly D. , Okun, Michael S. , Okun, Michael S , Wong, Joshua K , Shukla, Aparna Wagle

Mayo Clinic

Journal of Parkinson's Disease | August 20, 2021 | Volume: 11 | Issue: 4 | Pages: 1881-1885

10.3233/jpd-212820 | PMID 34420982 Get It

Deep brain stimulation (DBS) is an effective neuromodulatory therapy for Parkinson’s disease (PD). Early studies using globus pallidus internus (GPi) DBS for PD profiled the nucleus as having two functional zones. This concept disseminated throughout the neuromodulation community as the “GPi triangle”. Although our understanding of the pallidum has greatly evolved over the past 20 years, we continue to reference the triangle in our clinical decision-making process. We propose a new direction, termed the spatial boundary hypothesis, to build upon the 2-dimensional outlook on GPi DBS. We believe an updated 3-D GPi model can produce more consistent, positive patient outcomes.
Deep learning enabled ultra‐fast‐pitch acquisition in clinical X‐ray computed tomography
Gong, Hao , Ren, Liqiang , Hsieh, Scott S. , Yu, Lifeng , Gong, Hao , McCollough, Cynthia H. , Yu, Lifeng

Mayo Clinic

Medical Physics | August 20, 2021 | Volume: 48 | Issue: 10 | Pages: 5712-5726

10.1002/mp.15176 | PMID 34415068 Get It

AbstractObjectiveIn X‐raycomputed tomography (CT), many important clinical applications may benefit from a fast acquisition speed. The helical scan is the most widely used acquisition mode in clinical CT, where a fast helical pitch can improve the acquisition speed. However, on a typical single‐source helical CT (SSCT) system, the helical pitch p typically cannot exceed 1.5; otherwise, reconstruction artifacts will result from data insufficiency. The purpose of this work is to develop a deep convolutional neural network (CNN) to correct for artifacts caused by an ultra‐fast pitch, which can enable faster acquisition speed than what is currently achievable.MethodsA customized CNN (denoted as ultra‐fast‐pitch network (UFP‐net)) was developed to restore the underlying anatomical structure from the artifact‐corrupted post‐reconstruction data acquired from SSCT with ultra‐fast pitch (i.e., p ≥ 2). UFP‐net employed residual learning to capture the features of image artifacts. UFP‐net further deployed in‐house‐customized functional blocks with spatial‐domain local operators and frequency‐domain non‐local operators, to explore multi‐scale feature representation. Images of contrast‐enhanced patient exams (n = 83) with routine pitch setting (i.e., p < 1) were retrospectively collected, which were used as training and testing datasets. This patient cohort involved CT exams over different scan ranges of anatomy (chest, abdomen, and pelvis) and CT systems (Siemens Definition, Definition Flash, Definition AS+, Siemens Healthcare, Inc.), and the corresponding base CT scanning protocols used consistent settings of major scan parameters (e.g., collimation and pitch). Forward projection of the original images was calculated to synthesize helical CT scans with one regular pitch setting (p = 1) and two ultra‐fast‐pitch setting (p = 2 and 3). All patient images were reconstructed using the standard filtered‐back‐projection (FBP) algorithm. A customized multi‐stage training scheme was developed to incrementally optimize the parameters of UFP‐net, using ultra‐fast‐pitch images as network inputs and regular pitch images as labels. Visual inspection was conducted to evaluate image quality. Structural similarity index (SSIM) and relative root‐mean‐square error (rRMSE) were used as quantitative quality metrics.ResultsThe UFP‐net dramatically improved image quality over standard FBP at both ultra‐fast‐pitch settings. At p = 2, UFP‐net yielded higher mean SSIM (> 0.98) with lower mean rRMSE (< 2.9%), compared to FBP (mean SSIM < 0.93; mean rRMSE > 9.1%). Quantitative metrics at p = 3: UFP‐net—mean SSIM [0.86, 0.94] and mean rRMSE [5.0%, 8.2%]; FBP—mean SSIM [0.36, 0.61] and mean rRMSE [36.0%, 58.6%].ConclusionThe proposed UFP‐net has the potential to enable ultra‐fast data acquisition in clinical CT without sacrificing image quality. This method has demonstrated reasonable generalizability over different body parts when the corresponding CT exams involved consistent base scan parameters.
Evaluation of single bolus, dual-echo dynamic susceptibility contrast MRI protocols in brain tumor patients
Stokes, Ashley M. , Bergamino, Maurizio, Alhilali, Lea, Hu, Leland S, Karis, John P, Baxter, Leslie C, Bell, Laura C. , Quarles, C Chad, Bell, Laura C , Stokes, Ashley M , Bergamino, Maurizio, Alhilali, Lea, Hu, Leland S, Karis, John P, Baxter, Leslie C, Quarles, C Chad

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | August 20, 2021 | Volume: 41 | Issue: 12 | Pages: 3378-3390

10.1177/0271678x211039597 | PMID 34415211 Get It

Relative cerebral blood volume (rCBV) obtained from dynamic susceptibility contrast (DSC) MRI is adversely impacted by contrast agent leakage in brain tumors. Using simulations, we previously demonstrated that multi-echo DSC-MRI protocols provide improvements in contrast agent dosing, pulse sequence flexibility, and rCBV accuracy. The purpose of this study is to assess the in-vivo performance of dual-echo acquisitions in patients with brain tumors (n = 59). To verify pulse sequence flexibility, four single-dose dual-echo acquisitions were tested with variations in contrast agent dose, flip angle, and repetition time, and the resulting dual-echo rCBV was compared to standard single-echo rCBV obtained with preload (double-dose). Dual-echo rCBV was comparable to standard double-dose single-echo protocols (mean (standard deviation) tumor rCBV 2.17 (1.28) vs. 2.06 (1.20), respectively). High rCBV similarity was observed (CCC = 0.96), which was maintained across both flip angle (CCC = 0.98) and repetition time (CCC = 0.96) permutations, demonstrating that dual-echo acquisitions provide flexibility in acquisition parameters. Furthermore, a single dual-echo acquisition was shown to enable quantification of both perfusion and permeability metrics. In conclusion, single-dose dual-echo acquisitions provide similar rCBV to standard double-dose single-echo acquisitions, suggesting contrast agent dose can be reduced while providing significant pulse sequence flexibility and complementary tumor perfusion and permeability metrics.
Designing for Effective and Safe Multidisciplinary Primary Care Teamwork: Using the Time of COVID-19 as a Case Study
Lim, Lisa , Zimring, Craig , DuBose, Jennifer R. , Lee, Jaehoon , Stroebel, Robert J. , Matthews, Marc R. , Matthews, Marc R. , Lim, Lisa , Matthews, Marc R

Mayo Clinic

International Journal of Environmental Research and Public Health | August 20, 2021 | Volume: 18 | Issue: 16 | Pages: 8758

10.3390/ijerph18168758 | PMID 34444522 Get It

Effective medical teamwork can improve the effectiveness and experience of care for staff and patients, including safety. Healthcare organizations, and especially primary care clinics, have sought to improve medical teamwork through improved layout and design, moving staff into shared multidisciplinary team rooms. While co-locating staff has been shown to increase communication, successful designs balance four teamwork needs: face-to-face communications; situational awareness; heads-down work; perception of teamness. However, precautions for COVID-19 make it more difficult to conduct face-to-face communications. In this paper we describe a model for understanding how layout affects these four teamwork needs and describe how the perception of teamwork by staff changed after COVID-19 precautions were put in place. Observations, interviews and two standard surveys were conducted in two primary care clinics before COVID-19 and again in 2021 after a year of precautions. In general, staff felt more isolated and found it more difficult to conduct brief consults, though these perceptions varied by role. RNs, who spent more time on the phone, found it convenient to work part time-from home, while medical assistants found it more difficult to find providers in the distanced clinics. These cases suggest some important considerations for future clinic designs, including greater physical transparency that also allow for physical separation and more spaces for informal communication that are distanced from workstations.
Stem Cells to the Rescue: Development and Application of Cell-Based Therapy for Microvascular Repair
Lerman, Lilach O. , Lerman, Amir

Mayo Clinic

Cells | August 20, 2021 | Volume: 10 | Issue: 8 | Pages: 2144

10.3390/cells10082144 | PMID 34440914 Get It

The microcirculation includes an invisible network of micro-vessels that are up to a few hundred microns in diameter [...]
Fixed‐bearing unicompartmental knee arthroplasty provides a lower failure rate than mobile‐bearing unicompartimental knee arthroplasty when used after a failed high tibial osteotomy: a systematic review and meta‐analysis
Perelli, Simone , Raygoza-Cortez, Karina , Padilla‐Medina, José Ramón , Peña‐Martínez, Víctor M. , Zavala, José M. Diabb , Monllau, Juan Carlos , Barrera, Francisco J. , Perelli, Simone , Morales-Ávalos, Rodolfo , Guzman-Lopez, Santos , Vílchez‐Cavazos, Félix

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | August 20, 2021 | Volume: 30 | Issue: 9 | Pages: 3228-3235

10.1007/s00167-021-06707-4 | PMID 34415370 Get It

AbstractDespite the fact that the choice of bearing design has been thought to influence the functional outcomes and longevity of unicompartimental knee arthroplasty (UKA), there is a lack of clinical evidence supporting the decision‐making process in patients who have undergone high tibial osteotomy (HTO). A systematic review of studies was carried out that reported the outcomes of fixed‐bearing (FB) or mobile‐bearing (MB) medial UKA in patients with a previous HTO. A random effect meta‐analysis using a generalized linear mixed‐effects model to calculate revision rates was done. Seven retrospective cohort studies were included for this study. Regarding the fixation method, 40 were the FB‐UKA and 47 were MB‐UKA. For both groups, the mean post‐operative follow‐up was 5.8 years. The survival rates were 92% for the FB‐UKA with a mean follow‐up of 10 years. For the MB‐UKA, it ranged from 35.7 to 93%, with a mean follow‐up of 4.2 years. For the FB, the time to revision was reported as 9.3 years, while 1.2, 2.5 and 2.91 years was reported for the MB. The results of the meta‐analysis showed that the revision rate for the patients receiving a FB‐UKA after failed HTO was 8%, compared to 17% in those who received an MB‐UKA. The results of the review suggest that the use of the FB‐UKA is associated with lower revision rates and a longer survival time than the MB‐UKA and have similar functional ability scores.Level of evidence: III (systematic review of level‐III studies).
Prognostic Impact of the Presence of Barrett’s Esophagus and Intestinal Metaplasia on Esophageal Adenocarcinoma Survival
Fox, Charlie, Friedman, Chloe , Marsh, Megan, McCarter, Martin D. , Kaplan, Jeffrey , Gleisner, Ana , Katzka, David A. , Wani, Sachin , Kolb, Jennifer M. , Scott, Frank I. , Han, Samuel , Lieu, Christopher H.

Mayo Clinic

Foregut: The Journal of the American Foregut Society | August 20, 2021 | Volume: 2 | Issue: 4 | Pages: 356-364

10.1177/26345161211033277 | PMID 36578279 Get It

Background/Aims: Barrett’s esophagus (BE), defined by the presence of intestinal metaplasia (IM) on histology, is thought to be the only identifiable precursor lesion for esophageal adenocarcinoma (EAC). Recent studies have suggested the possibility of an alternate, non-IM associated EAC that is a more aggressive form of EAC with worse survival. Among EAC patients, we aimed to compare survival of patients with and without IM at the time of diagnosis. Methods: This was a retrospective cohort study of all patients with histologic confirmed EAC evaluated at a tertiary care center from 2013 to 2019. Cases were categorized according to the presence or absence of IM on histologic specimens (Group I—IM-EAC and Group II—non-IM-EAC). We compared demographic characteristics, clinical stage, therapy, and survival between the 2 groups using the Chi-square and ANOVA tests (for categorical and continuous variables, respectively). We used Cox proportional hazards regression to determine the association of IM with overall survival, adjusting for sex, age at diagnosis, tumor location, histologic grade, and clinical stage. Results: A total of 475 patients were included in this analysis (mean age 64.8 years [SD 10.8], 89% white) and 109 (23.0%) had no evidence of IM. Compared with IM-EAC (Group I), individuals in the non-IM-EAC group were younger ( P = .01) and had a greater proportion of patients diagnosed with advanced disease (49.5 vs 20.2% for stage 4, P < .001). These patients were less likely to undergo endoscopic therapy alone (0.92% vs 29.78%, P < .001) or surgery alone (0 vs 9.84%, P = .001). On multivariable analysis, the presence of IM-EAC was associated with improved overall survival compared to non-IM-EAC (HR 0.69, 95% CI 0.49-0.96). Additional factors associated with poor survival was increasing stage of diagnosis (HR 6.49: 95% CI 3.77-11.15 for stage 4, HR 2.19: 95% CI 1.25-3.84 for stage 3, HR 2.04: 95% CI 0.98-4.25 for stage 2 compared to stage 1) and more advanced histologic stage (HR 2.00, 95% CI 1.26-3.19) for poorly/undifferentiated compared to well differentiated). Conclusions: EAC without the presence of IM on histology was associated with worse survival compared to those with IM. Future prospective studies with detailed molecular sequencing are required to clarify if 2 separate phenotypes of EAC exist (IM-EAC and non-IM-EAC). If confirmed, this may have significant implications for screening and management strategies.
Early phase clinical studies of AR ‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas
Welling, D. Bradley , Collier, Katharine A. , Burns, Sarah S. , Oblinger, Janet L. , Shu, Edina , Miles‐Markley, Beth A., Slone, H. Wayne, Neff, Brian A., Jackler, Robert K. , Mortazavi, Amir , Chang, Long‐Sheng , Mansouri, Alireza , Jackler, Robert K , Mansouri, Alireza , Hofmeister, Craig C. , Makary, Mina S. , Blakeley, Jaishri O. , Mansouri, Sheila

Mayo Clinic

Laryngoscope Investigative Otolaryngology | August 20, 2021 | Volume: 6 | Issue: 5 | Pages: 1008-1019

10.1002/lio2.643 | PMID 34667843 Get It

Abstract Objectives Two pilot studies of AR‐42, a pan‐histone deacetylase inhibitor, in human neurofibromatosis type 2 (NF2), vestibular schwannomas (VS), and meningiomas are presented. Primary endpoints included safety, and intra‐tumoral pharmacokinetics (PK) and pharmacodynamics (PD). Methods Pilot 1 is a subset analysis of a phase 1 study of AR‐42 in solid tumors, which included NF2 or sporadic meningiomas. Tumor volumes and treatment‐related adverse events (TRAEs) are reported (NCT01129193). Pilot 2 is a phase 0 surgical study of AR‐42 assessing intra‐tumoral PK and PD. AR‐42 was administered for 3 weeks pre‐operatively. Plasma and tumor drug concentrations and p‐AKT expression were measured (NCT02282917). Results Pilot 1: Five patients with NF2 and two with sporadic meningiomas experienced a similar incidence of TRAEs to the overall phase I trial. The six evaluable patients had 15 tumors (8 VS, 7 meningiomas). On AR‐42, tumor volume increased in six, remained stable in eight, and decreased in one tumor. The annual percent growth rate decreased in eight, remained stable in three, and increased in four tumors. Pilot 2: Four patients with sporadic VS and one patient with meningioma experienced no grade 3/4 toxicities. Expression of p‐AKT decreased in three of four VS. All tumors had higher AR‐42 concentrations than plasma. Conclusions AR‐42 is safe. Tumor volumes showed a mixed response, but most slowed growth. On a 40‐mg regimen, drug concentrated in tumors and growth pathways were suppressed in most tumors, suggesting this may be a well‐tolerated and effective dose. A phase 2 study of AR‐42 for NF2‐associated tumors appears warranted. Level of Evidence 1b, 4.